93 related articles for article (PubMed ID: 12931238)
1. Transduction of hematopoietic stem cells with a retroviral vector expressing the neomycin phosphotransferase gene.
Link CJ; Seregina T; Edleman M; Young WB; Burt RK; Kisselev S
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S33-5. PubMed ID: 12931238
[TBL] [Abstract][Full Text] [Related]
2. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
[TBL] [Abstract][Full Text] [Related]
3. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model.
Heim DA; Hanazono Y; Giri N; Wu T; Childs R; Sellers SE; Muul L; Agricola BA; Metzger ME; Donahue RE; Tisdale JF; Dunbar CE
Mol Ther; 2000 Jun; 1(6):533-44. PubMed ID: 10933978
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a retroviral vector for transduction of human CD34 positive cells.
Szyda A; Paprocka M; Krawczenko A; Lenart K; Heimrath J; Grabarczyk P; Mackiewicz A; Duś D
Acta Biochim Pol; 2006; 53(4):815-23. PubMed ID: 17160143
[TBL] [Abstract][Full Text] [Related]
5. Retroviral transduction of hematopoietic progenitors derived from human embryonic stem cells.
Menendez P; Wang L; Cerdan C; Bhatia M
Methods Mol Biol; 2006; 331():201-20. PubMed ID: 16881519
[TBL] [Abstract][Full Text] [Related]
6. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
7. Retroviral integration sites correlate with expressed genes in hematopoietic stem cells.
Wagner W; Laufs S; Blake J; Schwager C; Wu X; Zeller JW; Ho AD; Fruehauf S
Stem Cells; 2005 Sep; 23(8):1050-8. PubMed ID: 16140869
[TBL] [Abstract][Full Text] [Related]
8. Murine hematopoietic stem cell transduction using retroviral vectors.
Modlich U; Schambach A; Li Z; Schiedlmeier B
Methods Mol Biol; 2009; 506():23-31. PubMed ID: 19110617
[TBL] [Abstract][Full Text] [Related]
9. In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
Shi PA; De Angioletti M; Donahue RE; Notaro R; Luzzatto L; Dunbar CE
J Gene Med; 2004 Apr; 6(4):367-73. PubMed ID: 15079811
[TBL] [Abstract][Full Text] [Related]
10. Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor.
Pan D; Stroncek DF; Whitley CB
J Gene Med; 2004 Dec; 6(12):1293-303. PubMed ID: 15538732
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
14. The use of retroviral vectors for gene transfer into hematopoietic stem cells.
Holst J; Rasko JE
Methods Enzymol; 2006; 420():82-100. PubMed ID: 17161695
[No Abstract] [Full Text] [Related]
15. Genetically modified CD34+ cells do not contribute to the mesenchymal compartment after autologous transplantation in the baboon.
Keyser KA; Morris JC; Kiem HP
Cytotherapy; 2005; 7(4):345-52. PubMed ID: 16162456
[TBL] [Abstract][Full Text] [Related]
16. Retroviral transduction of hematopoietic cells differentiated from human embryonic stem cell-derived CD45(neg)PFV hemogenic precursors.
Menendez P; Wang L; Chadwick K; Li L; Bhatia M
Mol Ther; 2004 Dec; 10(6):1109-20. PubMed ID: 15564142
[TBL] [Abstract][Full Text] [Related]
17. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.
Zhang J; Attar E; Cohen K; Crumpacker C; Scadden D
Gene Ther; 2005 Oct; 12(19):1444-52. PubMed ID: 15877047
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
[TBL] [Abstract][Full Text] [Related]
19. Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells.
Kurre P; Anandakumar P; Kiem HP
Gene Ther; 2006 Feb; 13(4):369-73. PubMed ID: 16208421
[TBL] [Abstract][Full Text] [Related]
20. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
Oh IH; Fabry ME; Humphries RK; Pawliuk R; Leboulch P; Hoffman R; Nagel RL; Eaves C
Exp Hematol; 2004 May; 32(5):461-9. PubMed ID: 15145214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
